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INTRODUCTION 
Non - prescription medicines (NPM) have become a major pillar of healthcare systems. 
Individual countries apply their politics of health care by implementation of legislation and 
rules which govern entry and access of NPM to the market. Among the main stakeholders 
who play an important role in regulation and safety of NPM in the Czech Republic (CZ) are 
the Government, Ministries, State Institute for Drug Control (SIDC), manufacturers and 
distributors, associations of manufacturers and consumers, healthcare professionals, and 
finally consumers. 
OBJECTIVES 
The aim of the theoretical part of our research was analysis of the legislative framework for 
NPM in CZ and to assess if the current legislation and educational environment for NPM can 
ensure safety of patients in their self-medication with NPM. 
METHODS 
For the theoretical part literature and internet research reviews have been conducted. The 
experimental part comprised of three studies analysing relations and behaviour of 
stakeholders which play an important role in the process of self-medication with NPM. 
RESULTS 
Theoretical part 
Important steps to the deregulation of OTC market started in the European Union (EU) in 
2001. In the Czech Republic this process has started in 2007, when SIDC initiated the switch 
of several active substances to the category of NPM and introduced a new NPM category - 
NPM with restriction. Legislation in CZ which governs in CZ non-prescription drugs is fully 
harmonized with EU legislation. Prescription status is however granted by SIDC within the 
framework of the drug registration process. The EU has recently strengthened requirements 
on pharmacovigilance for medicines and started the process of continuous re-assessment of 
safety and efficacy profiles of human medicinal products. As a result of this process 
additional safety measures are implemented which should lead to increased safety of 
medicines.  
Experimental part 
Adverse drug reactions reporting in the Czech Republic 2005 - 2009 
Aim: The aim of this study was to assess the process regarding spontaneous adverse drug 
reaction (SADR) reporting in the Czech Republic during a five year period (2005 - 2009), to 
compare the data with the data from three other EU countries, and with the data from Czech 
Toxicological Information Centre (TIS) recorded on drug intoxications.  
Methods: Spontaneous adverse drug reaction reports received by the pharmacovigilance 
department of Czech State Institute for Drug Control (SIDC) during 2005 - 2009 were 
collected, analysed and compared with the SADR report data from the Slovak Republic, 
Denmark, and the United Kingdom. We analysed the following data: number of reported 
SADR, reporters, qualification of reporters, seriousness and outcome of serious adverse drug 
reaction, the list of “top 10“ active substances with highest number of SADR. The following 
data were generated and analysed from TIS database for the same period: all intoxications, 
drug intoxications, reports on individual drug groups.  
Results: During the study period 2005 - 2009, the pharmacovigilance department of SIDC 
received 7,708 SADR reports of which 73.6 % were serious and 2.1 % resulted in death. The 
number of SADR reports per 10,000 inhabitants ranged from 1.3 to 1.7, which was lower 
when compared with the number of reports from the other three EU countries. The healthcare 
professionals contributed 64.2 % of the adverse drug reactions reports, marketing 
authorization holders 35.5 %, and patients 0.3 %. The highest numbers of SADR reports were 
for vaccines, ketoprofen, amoxicillin, statins, and estradiol. In the same period TIS recorded 
50,613 calls of which 21,117 were related to drug intoxications. The most frequent drugs 
reports that TIS receives are for ibuprofen and paracetamol. 
Conclusions: This study assessing SADR reports received by SIDC during a five year period 
2005 - 2009 showed that the reporting rate was relatively low. To help facilitate an increase in 
spontaneous reporting, it is recommended that more educational and training activities are 
needed for all potential reporters to increase their knowledge regarding what should be 
reported, how and to whom to report and also to emphasize the importance of reporting and 
the implications for the safety of the Czech Republic population as a whole. Another 
important recommendation is that it would be beneficial to have connection link between the 
two databases (SIDC and TIS) to help to collect more information about adverse drug 
reactions and additional information about safety of drugs from real life use.  
 
Role of pharmacists in the selection and safety of non-prescription medicines  
Aim: The aim of this study was to assess the factors affecting pharmacist’s decision when 
recommending non-prescription medicines (NPM). The study looked at pharmacists‘opinion 
on regulation and safety of NPM and explored their knowledge of detecting and reporting of 
adverse drug reactions.  
Methods: A cross-sectional study was conducted in the Czech Republic. The study sample 
was members of Czech Chamber of Pharmacists, who were approached via the Journal of 
Czech Pharmacists. A questionnaire with 40 questions was posted on the website of Czech 
Chamber of Pharmacists. Part of the survey was a Pharmacovigilance test, which contained 
10 questions focussing on legislation and procedure for adverse drug reporting. Statistical 
analysis of data used SPSS
®
 16.0 software and parametric and non-parametric statistical tests 
were used.  
Results: In total 283 (3.6 %) registered pharmacists completed the survey. The respondents 
comprised of 79.9 % females and 20.1 % of males, with mean age 39.4 (±11.2) years and 
ranged from 25 to 67 years in age (median 37 years). Pharmacists from all regions and town 
size of the Czech Republic were represented. The majority of pharmacists (67.5 %) reported 
that their pharmacy had a separate sale counter for the NPM. Most of the pharmacists 
responded (88.4 %) that they have sufficient time to provide advice to patients for NPM, but 
only 49.1 % of them reported that they have sufficient information about patients to be able 
to make qualified decision on the choice of NPM to recommend to patients. For more than 90 
% of pharmacists the main factors affecting their choice of NPM are health problems 
described by the patient, active substance and additional information obtained from patient 
regarding his/her general health. Economic factors of pharmacy such as profit for pharmacy 
or goods on stock with short expiration period played the less importance. Only 56.2 % of 
pharmacists reported that they would report adverse drug reaction to Drug Agency. Those 
who reported in their lifetime (25.2 %) indicated that they had reported ADRs only in 49.8 % 
to the Czech Drug Agency. Czech Drug Agency plays a key role for pharmacists (85.4 %) in 
providing information regarding the safety of the drugs. The Pharmacovigilance test was 
completed by 208 (73.5 %) of pharmacists who scored on average 7.2 (± 1.4) of correct 
answers. 
Conclusions: The study found that pharmacists play a key a role in the selection and 
recommendation of NPM. Access to patient’s health records would improve qualified choice 
of NPM for individual patient. The pharmacists have the ability to detect the drug related 
problems and therefore can contribute to improving the safety of NPM, in prevention of drug 
related problems and in reporting of ADR. The study recommends training pharmacists in 
pharmacovigilance, and that the Czech Drug Agency, universities and Czech Chamber of 
Pharmacists would be the most appropriate bodies to undertake this role. 
Use of medicines among students of high schools in the Czech Republic  
Aim of the study: To examine the prevalence and type of medicines used among high school 
students in the Czech Republic, to collect students’ experience with drug related problems 
and to explore their knowledge on the drug use and the source of drug information they are 
using for self-medication and drug related problems. 
Methods: A cross-sectional study was conducted in high schools in the Czech Republic. The 
study sample was a student population from nine high schools from two regions and three 
towns. Questionnaires respecting anonymity were distributed to the students during a regular 
class period. Students answered closed and semi-opened questions, 48 (for males) and 51(for 
females), divided into seven sections focussing on their experience with chronic and short 
term use of medicine, medicine used during last six months, conditions treated, type and 
source of the used medicines. The study was carried out from April to June 2010. Poisson 
regression model with a robust variance estimator (sandwich) was used for statistical analysis 
as well as chi- quadrat test.  
Results: In total, 979 students, aged 14–21 years (mean age 17 years) participated in the 
study: 310 (32 %) were male and 669 (68 %) female. 177 (19 %) of students reported regular 
use of medicines for chronic disease. The use of medicines during the last 6 months was 
reported by 811 (83 %) of students; 342 (43 %) of them reported the use of both prescription 
and over-the counter (OTC) medicines; 205 (22 %) the use only of OTC, and 249 (31 %) 
only prescription medicines. Allergy (8.1%), asthma (2.6 %), and disorders of the thyroid 
gland (2.1 %) were among the most frequent long-term diseases. The most frequent groups of 
medicines used for the treatment of long-term diseases were systemic antihistamines 
(46.9 %), thyroid preparations (9.0 %), and respiratory drugs (7.9 %). Non-steroidal anti-
inflammatory medicines, ibuprofen (84.2 %) and paracetamol (44.0 %) were the most 
frequently used non-prescription active substances during last six months.  
About 86.0 % of students admitted self-medication during their lifetime. Out of 780 students, 
38.0 % remembered that they experienced a drug related problem at some point in their life. 
Out of 981 students 38.1 % admitted drug non-compliance. The student’s mother was the 
most frequent person who disposed the drug to adolescents (43.9 %), and home medicine 
cabinet (77.8 %) was the main source of drugs. The most frequent source of information for 
students was the physician 70.1 %, followed by pharmacist 53.3 % and mother 48.3 %. 
Students were familiar with indications for paracetamol and ibuprofen but have very poor 
knowledge regarding the safety of the drugs. Statistically significant associations were found 
between use of medicines during last 6 months and type of school, sex and chronic diseases, 
and between self-medication and sex.  
Conclusions: The study results showed quite extensive use of both prescription and OTC 
medicines in students of high schools in the Czech Republic and their wide experience with 
self-medication and drug related problems. Students tend to try and resolve drug related 
problems as well as obtaining information about drugs from non-healthcare professionals. 
From these results it highlights that there is a need of increased communication between 
students, parents, teachers and healthcare professionals to ensure an appropriate level of 
understanding of the risks and benefits of drug use.  
CONCLUSION 
The legislative environment in CZ provides a good basis for safety of NPM. Czech Drug 
Agency plays a key advisory role for management of pharmacies and the implementation of 
good practices to ensure safety and efficacy of NPM. Our data demonstrated the need for 
additional educational activities for all who participate in the process of self - medication.  
  
